The Propagation and Quantification of Two Emerging Oncolytic Viruses: Vesicular Stomatitis (VSV) and Zika (ZIKV)

Robert E Means1, Sounak Ghosh Roy1, Samuel G Katz2

  • 1Department of Pathology, Yale School of Medicine, New Haven, CT, USA.

Insights

Researchers are exploring viruses like vesicular stomatitis virus and Zika virus as cancer therapies. This study details methods for propagating these viruses and testing their ability to kill glioblastoma cells.

Area of Science:

  • Oncolytic virotherapy
  • Virology
  • Cancer biology

Background:

  • Genetic engineering advances enable virus-based cancer treatments.
  • Vesicular stomatitis virus (VSV) and Zika virus show promise for oncolysis.
  • Targeting cancer cells via viral lysis or immune response is a key strategy.

Purpose of the Study:

  • To establish methods for propagating and titering VSV and Zika virus.
  • To develop a cell-killing assay for evaluating modified oncolytic viruses.
  • To assess the potential of VSV and Zika virus against glioblastoma.

Main Methods:

  • Virus propagation techniques for VSV and Zika virus.
  • Viral titration assays to determine infectious units.
  • Cell-based assays to measure viral-induced glioblastoma cell death.

Main Results:

  • Protocols for reliable VSV and Zika virus propagation were established.
  • A straightforward cell-killing assay was developed.
  • Initial data suggests potential for viral-mediated glioblastoma cell killing.

Conclusions:

  • VSV and Zika virus can be effectively propagated and titered.
  • The developed assay is suitable for screening oncolytic virus efficacy.
  • Further research into modified VSV and Zika virus for glioblastoma treatment is warranted.

Related Concept Videos

Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...